DD Group Acquires Specialist Aesthetics Supplier & Pharmacy Fox Pharma Ltd

DD Group is excited to announce the acquisition of Fox Pharma Ltd, a leading UK-based aesthetics supplier and pharmacy.

The acquisition further strengthens DD Group’s aesthetics offering and expands its training and support capabilities for clinics across the UK and Ireland, alongside its established aesthetics brand, Medfx. It positions the Group as a comprehensive partner to aesthetics and dental practitioners.

Fox Pharma brings specialist expertise in aesthetics products, a broad and highly regarded product range, and strong training and clinic support capabilities. Its portfolio includes exclusive products across dermal fillers, skin boosters, chemical peels, and polynucleotides. Founded seven years ago, Fox Pharma has built a strong reputation within the sector for exceptional customer service, quality, and reliability.

This acquisition enhances DD Group’s existing capabilities in aesthetics and supports continued growth across the UK, Ireland, and Europe.

Howard Taylor, CEO of DD Group, said:

“Fox Pharma has an excellent reputation in the aesthetics sector. They are known for their exceptional service, strong product portfolio, and medical professional-led training. I am delighted to welcome the very talented Fox team into the DD Group, and I look forward to working closely with them to further develop and grow our aesthetics offering in the UK, Ireland and beyond at pace.”

John Thompson, Managing Director of Fox Pharma, added:

“This is an exciting move for both Fox Pharma and Medfx. The strength and experience we can offer by joining forces will enable us to continue to be a driving force in the aesthetics market. Our alignment on customer-centric values and the quality and safety of product supplies makes this a seamless partnership.”